{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:40:03Z","timestamp":1780422003487,"version":"3.54.1"},"reference-count":32,"publisher":"Tokyo Dental College","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bull. Tokyo Dent. Coll."],"published-print":{"date-parts":[[2018]]},"DOI":"10.2209\/tdcpublication.2016-0052","type":"journal-article","created":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T18:48:48Z","timestamp":1521485328000},"page":"27-34","source":"Crossref","is-referenced-by-count":8,"title":["Fatal Bleeding in Conjunction with Mandibular Medication-related Osteonecrosis of the Jaw (MRONJ)"],"prefix":"10.2209","volume":"59","author":[{"given":"Taiki","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Hachioji Hospital Tokai University"},{"name":"Department of Oral Medicine, Oral and Maxillofacial Surgery, Tokyo Dental College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Sekiya","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Hachioji Hospital Tokai University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Hamada","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Hachioji Hospital Tokai University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Hachioji Hospital Tokai University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Karakida","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Hachioji Hospital Tokai University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruo","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Hachioji Hospital Tokai University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1039","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Asaka T, Makino S, Takano M, Abe T, Abiko Y, Kitagawa Y (2013) Immediate reconstruction after segmental mandiblectomy in a patient with refractory osteomyelitis of the jaw cased by oral bisphosphonate therapy. Nihon Koku Geka Gakkai Zasshi 59: 182\u2013186. (in Japanese)","DOI":"10.5794\/jjoms.59.182"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Asaka Y, Makita H, Yoneyama K, Yamashita T, Kato K, Shibata T (2009) Successful surgical treatment of a case of bisphosphonate-related osteonecrosis of the mandible. Nihon Koku Geka Gakkai Zasshi 55: 354\u2013358. (in Japanese)","DOI":"10.5794\/jjoms.55.354"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Ayllon J, Launay-Vacher V, Medioni J, Cros C, Spano JP, Oudard S (2009) Osteonecrosis of the jaw under bisphosphonate and antiangiogenic therapies: Cumulative toxicity profile? Ann Oncol 20: 600\u2013601.","DOI":"10.1093\/annonc\/mdn788"},{"key":"4","unstructured":"4) Balmor GR, Yarom N, Weitzen R (2012) Druginduced palate osteonecrosis following nasal surgery. Isr Med Assoc J 14: 193\u2013194."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Beuselinck B, Wolter P, Karadimou A, Elaidi R, Dumez H, Rogiers A, Van Cann T, Willems L, Body JJ, Berkers J, Van Poppel H, Lerut E, Debruyne P, Paridaens R, Sch\u00f6ffski P (2012) Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases. Br J Cancer 107: 1665\u20131671.","DOI":"10.1038\/bjc.2012.385"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Bozas G, Roy A, Ramasamy V, Maraveyas A (2010) Osteonecrosis of the jaw after a single bisphosphonate infusion in a patient with metastatic renal cancer treated with sunitinib. Onkologie 33: 321\u2013323.","DOI":"10.1159\/000313680"},{"key":"7","unstructured":"7) Cancer statistics (2003) Death rates adjusted for age due to malignant neoplasms (1950\u20132001); http:\/\/www.ncc.go.jp\/jp"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Christodoulou C, Pervena A, Klouvas G, Galani E, Falagas ME, Tsakalos G, Visvikis A, Nikolakopoulou A, Acholos V, Karapanagiotidis G, Batziou E, Skarlos DV (2009) Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone. Oncology 76: 209\u2013211.","DOI":"10.1159\/000201931"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Coleman R, Woodward E, Brown J, Cameron D, Bell R, Dodwell D, Keane M, Gil M, Davies C, Burkinshaw R, Houston SJ, Grieve RJ, Barrett-Lee PJ, Thorpe H (2011) Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01\u201304) for women with stage II\/III breast cancer. Breast Cancer Res Treat 127: 429\u2013438.","DOI":"10.1007\/s10549-011-1429-y"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Critz FA, Benton JB, Shrake P, Merlin ML (2013) 25-Year disease-free survival rate after irradiation for prostate cancer calculated with the prostate specific antigen definition of recurrence used for radical prostatectomy. J Urol 189: 878\u2013883.","DOI":"10.1016\/j.juro.2012.10.061"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C; FREEDOM Trial (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361: 756\u2013765.","DOI":"10.1056\/NEJMoa0809493"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Engroff SL, Kim DD (2007) Treating bisphosphonate osteonecrosis of the jaws: Is there a role for resection and vascularized reconstruction. J Oral Maxillofac Surg 65: 2374\u20132385.","DOI":"10.1016\/j.joms.2006.07.012"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Ferrari S, Bianchi B, Savi A, Poli T, Multinu A, Balestreri A, Ferri A (2008) Fibula free flap with endosseous implants for reconstructing a resected mandible in bisphosphonate osteonecrosis. J Oral Maxillofac Surg 66: 999\u20131003.","DOI":"10.1016\/j.joms.2007.06.631"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Fleissig Y, Regev E, Lehman H (2012) Sunitinib related osteonecrosis of jaw: A case report. Oral Surg Oral Med Oral Pathol Oral Radiol 113: e1\u2013e3.","DOI":"10.1016\/j.tripleo.2011.06.023"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Guarneri V, Miles D, Robert N, Di\u00e9ras V, Glaspy J, Smith I, Thomssen C, Biganzoli L, Taran T, Conte P (2010) Bevacizumab and osteonecrosis of the jaw: Incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer. Breast Cancer Res Treat 122: 181\u2013188.","DOI":"10.1007\/s10549-010-0866-3"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Hariya Y, Sekiguchi T, Okita M, Harada M, Ohuchi T (2008) Surgical intervention of osteonecrosis of the maxilla associated with bisphosphonate therapy: report of a case. Nihon Koku Geka Gakkai Zasshi 54: 413\u2013417. (in Japanese)","DOI":"10.5794\/jjoms.54.413"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Hoefert S, Eufinger H (2010) Sunitinib may raise the risk of bisphosphonate-related osteonecrosis of the jaw: presentation of three cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110: 463\u2013469.","DOI":"10.1016\/j.tripleo.2010.04.049"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Koch FP, Walter C, Hansen T, J\u00e4ger E, Wagner W (2011) Osteonecrosis of the jaw related to sunitinib. J Oral Maxillofac Surg 15: 63\u201366.","DOI":"10.1007\/s10006-010-0224-y"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Kumar SK, Gorur A, Schaudinn C, Shuler CF, Costerton JW, Sedghizadeh PP (2010) The role of microbial biofilms in osteonecrosis of the jaw associated with bisphosphonate therapy. Curr Osteoporos Rep 8: 40\u201348.","DOI":"10.1007\/s11914-010-0008-1"},{"key":"20","unstructured":"20) Kuroishi T, Hirose K (2004) Prediction of the cancer death rate in Japan. Cancer statistics white paper\u2014cancer-bearing\/death\/prognoses 2004, Oshima A, Kuroishi T, Tajima K (Eds), pp.219\u2013234, Shinoharashinsha Publishers, Tokyo."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Mauri D, Valachis A, Polyzos IP, Polyzos NP, Kamposioras K, Pesce LL (2009) Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: A meta-analysis. Breast Cancer Res Treat 116: 433\u2013439.","DOI":"10.1007\/s10549-009-0432-z"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Nicolatou-Galitis O, Migkou M, Psyrri A, Bamias A, Pectasides D, Economopoulos T, Raber-Durlacher JE, Dimitriadis G, Dimopoulos MA (2012) Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: report of 2 cases with clinical implications. Oral Surg Oral Med Oral Pathol Oral Radiol 113: 234\u2013238.","DOI":"10.1016\/j.tripleo.2011.08.024"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Papapoulos S, Chapurlat R, Libanati C, Brandi ML, Brown JP, Czerwi\u0144ski E, Krieg MA, Man Z, Mellstr\u00f6m D, Radominski SC, Reginster JY, Resch H, Rom\u00e1n Ivorra JA, Roux C, Vittinghoff E, Austin M, Daizadeh N, Bradley MN, Grauer A, Cummings SR, Bone HG (2012) Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension. J Bone Miner Res 27: 694\u2013701.","DOI":"10.1002\/jbmr.1479"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Qi WX, Tang LN, He AN, Yao Y, Shen Z (2014) Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials. Int J Clin Oncol 19: 403\u2013410.","DOI":"10.1007\/s10147-013-0561-6"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O'Ryan F; American Association of Oral and Maxillofacial Surgeons (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u2014 2014 update. J Oral Maxillofac Surg 72: 1938\u20131956.","DOI":"10.1016\/j.joms.2014.04.031"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Scagliotti GV, Hirsh V, Siena S, Henry DH, Woll PJ, Manegold C, Solal-Celigny P, Rodriguez G, Krzakowski M, Mehta ND, Lipton L, Garc\u00eda-S\u00e1enz JA, Pereira JR, Prabhash K, Ciuleanu TE, Kanarev V, Wang H, Balakumaran A, Jacobs I (2012) Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: Subgroup analysis from a randomized phase 3 study. J Thorac Oncol 7: 1823\u20131829.","DOI":"10.1097\/JTO.0b013e31826aec2b"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Sedghizadeh PP, Kumar SK, Gorur A, Schaudinn C, Shuler CF, Costerton JW (2008) Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy. J Oral Maxillofac Surg 66: 767\u2013775.","DOI":"10.1016\/j.joms.2007.11.035"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Seth R, Futran ND, Alam DS, Knott PD (2010) Outcomes of vascularized bone graft reconstruction of the mandible in bisphosphonaterelated osteonecrosis of the jaws. Laryngoscope 120: 2165\u20132171.","DOI":"10.1002\/lary.21062"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Smidt-Hansen T, Folkmar TB, Fode K, Agerbaek M, Donskov F (2013) Combination of zoledronic acid and targeted therapy is active but may induce osteonecrosis of the jaw in patients with metastatic renal cell carcinoma. J Oral Maxillofac Surg 71: 1532\u20131540.","DOI":"10.1016\/j.joms.2013.03.019"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Suzuki T, Hamada U, Takahashi M, Karakida K, Sakamoto H (2017) A clinical research on prognoses of the medication-related osteonecrosis of the jaw (MRONJ). Jpn J Oral Diag\/ Oral Med 30: 327\u2013332.","DOI":"10.15214\/jsodom.30.327"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Wanger G, Gorby Y, El-Naggar MY, Yuzvinsky TD, Schaudinn C, Gorur A, Sedghizadeh PP (2013) Electrically conductive bacterial nanowires in bisphosphonate-related osteonecrosis of the jaw biofilms. Oral Surg Oral Med Oral Pathol Oral Radiol 115: 71\u201378.","DOI":"10.1016\/j.oooo.2012.08.446"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Yoneda T, Hagino H, Sugimoto T, Ohta H, Takahashi S, Soen S, Taguchi A, Toyosawa S, Nagata T, Urade M (2010) Bisphosphonaterelated osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons. J Bone Miner Metab 28: 365\u2013383.","DOI":"10.1007\/s00774-010-0162-7"}],"container-title":["The Bulletin of Tokyo Dental College"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tdcpublication\/59\/1\/59_2016-0052\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T00:15:26Z","timestamp":1570925726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tdcpublication\/59\/1\/59_2016-0052\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2209\/tdcpublication.2016-0052","relation":{},"ISSN":["0040-8891"],"issn-type":[{"value":"0040-8891","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}